Home / Treatment Library / Physician-Supervised Peptide Therapy
Evidence, sourcing and supervision first. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Your symptoms, health history, laboratory data and long-term goals shape the conversation from the beginning.
A peptide is a short chain of amino acids. Some peptide medicines are FDA-approved for specific diseases; many products promoted online for anti-aging, healing, muscle gain or weight loss are investigational, unapproved or labeled “research use only.” Therapy should begin with diagnosis and product-specific evidence—not a peptide trend.
Candidacy exists only when a licensed clinician identifies a legitimate clinical goal, an evidence-supported product or carefully justified compounded need, and a monitoring plan. The fact that a substance is a peptide does not make it safe or appropriate.
Do not use products sold without a valid prescription, labeled for research use only, shipped from unknown sources or promoted with guaranteed cures. Pregnancy, cancer risk, endocrine disease, medication interactions and organ dysfunction may change suitability depending on the specific drug.
These are practical planning ranges, not promises. Your consultation determines the exact plan.
A physician reviews symptoms, diagnoses, medicines, goals and whether established treatments should come first.
The exact molecule, FDA status, human evidence, risks, pharmacy and legal availability are reviewed. “Peptide” is never treated as one category of efficacy.
If a legitimate therapy is appropriate, prescription, monitoring and stopping rules are documented. Patients are directed to the Peptide Education Center for deeper evidence.
Unknown-source products may be counterfeit, contaminated, incorrectly dosed, nonsterile or a different substance entirely. Potential harm includes infection, allergic reaction, endocrine disruption, blood-sugar changes, organ injury, tumor-related concerns and permanent harm. Compounded drugs are not FDA-approved and do not undergo premarket review for safety, effectiveness or quality.
A well-versed physician distinguishes an approved medication from a marketing label, verifies the pharmacy and prescription pathway, monitors measurable outcomes and refuses products whose evidence or source does not support safe care.
Consultations and appropriate follow-up may be in-office or by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to law and clinical eligibility. Labs or in-person examination may be required.
Pricing: Consultation required. Laboratory testing is included in the program. Cost depends on the evaluation, the legally available medication, pharmacy and follow-up. No specific peptide or prescription is guaranteed.
Review FDA-approved peptide medicines, investigational compounds, sourcing safeguards, evidence grading and individual peptide guides.
When a prescription or compounded preparation is clinically appropriate, the dispensing pharmacy, facility classification and current license status matter. Compounded medications are not FDA-approved drug products.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Physician-Supervised Peptide Therapy—or an alternative—makes sense.
